Key Takeaways
- Rocket Lab shares gained 2.3% to $82.08 following Viasat’s selection of the company to construct a satellite bus for the Space Force’s Protected Tactical SATCOM-Global initiative.
- Stifel’s Erik Rasmussen characterized the Viasat contract as an eight-figure opportunity and maintains a Buy rating with a $132 price objective.
- Second-quarter revenue reached $234.1 million, representing a 62% increase from the prior year, though adjusted EPS came in at a $0.08 loss versus consensus expectations of a $0.06 loss.
- The company maintains approximately $2.36 billion in contracted backlog and recently launched eight satellites for MDA Space and Globalstar as part of a $143 million agreement.
- Buy ratings comprise 82% of analyst recommendations, with a consensus price target near $117, although significant insider selling activity over the last three months has weighed on investor sentiment.
Shares of Rocket Lab (RKLB) advanced 2.3% to reach $82.08 on Monday following an announcement that Viasat had selected the aerospace company to construct a satellite bus for the United States Space Force. This contract forms part of Viasat’s Protected Tactical SATCOM-Global initiative, a program that leverages commercial satellite providers to deliver secure military communications capabilities.
During Monday’s trading session, the stock reached an intraday peak of $85.55. Total trading volume registered approximately 17.9 million shares, running about 25% lighter than typical daily volume.
Erik Rasmussen, an analyst at Stifel, described the Viasat contract as an eight-figure revenue opportunity for Rocket Lab and suggested additional similar agreements could materialize in the future. Rasmussen maintains a Buy recommendation on RKLB with a price target of $132.
This Space Force contract win comes during an active operational period for the company. Rocket Lab recently successfully deployed eight satellites on behalf of MDA Space and Globalstar, representing the initial portion of a 17-satellite deployment under a $143 million agreement. All eight spacecraft achieved orbit successfully, established communications, and entered the commissioning phase.
Monday’s price appreciation brings RKLB’s gains to over 20% during the past month. Despite this rally, the stock remains considerably below its 52-week peak of more than $150, which was reached in May prior to the anticipated SpaceX IPO.
Revenue Surge Offset by Earnings Shortfall
Rocket Lab delivered second-quarter revenue of $234.1 million, representing nearly 62% growth compared to the year-ago period and marginally exceeding the consensus forecast of $231.6 million. This level of top-line expansion represents exceptional performance by most standards.
Despite the revenue beat, the company posted an adjusted loss of $0.08 per share, falling short of analyst expectations for a $0.06 loss. Company management attributed the larger-than-anticipated loss to integration expenses and shifts in business mix that pressured profit margins.
Rocket Lab currently maintains a contract backlog totaling approximately $2.36 billion, demonstrating robust demand from commercial, government, and defense sector clients.
Wall Street Coverage and Insider Transactions
Approximately 82% of analysts who cover RKLB maintain Buy ratings, substantially higher than the 55-60% Buy-rating percentage typical of S&P 500 constituents. The consensus analyst price target stands at approximately $117, well above the current trading level of $82.08.
Piper Sandler recently launched coverage with a neutral stance and an $83 price objective. In May, Deutsche Bank elevated its price target from $73 to $120 while maintaining a Buy rating.
However, sentiment indicators haven’t been uniformly positive. Company insiders have divested approximately 3.75 million stock units valued at roughly $351 million during the past 90 days, including transactions by CEO Peter Beck. SVP Arjun Kampani sold 88,000 units in June at an average execution price of $107.98.
Rocket Lab’s market capitalization currently stands at approximately $50 billion, translating to roughly 40 times projected sales over the next 12 months. Three years ago, this sales multiple stood at around 7 times.
Institutional investors have demonstrated strong buying interest. BlackRock established a new position during Q2 valued at approximately $4.1 billion. Vanguard expanded its holdings by 13.4% in Q4. Institutional ownership now represents about 71.78% of outstanding shares.





